oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Flegafortan

It was found that the patient leaflet regarding recommended dosing was inconsistent with the Summary of Product Characteristics, which could lead to incorrect use of the product and overdose manifested by unintended increased volume of bronchial secretions. Potential effects: overdose, increased bronchial secretion, respiratory complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Flegafortan
Risk Level
High
Manufacturer
Aflofarm Farmacja Polska Sp. z o.o.
Batch Number
0131G
EAN Code
05909991358150
Recall Date
14.02.2020
View official statement

Important Information

What You Should Know

Recommendations

Patients should use Flegafortan in accordance with the current leaflet and the recommendations of a doctor or pharmacist; in case of any doubts about dosing, they should consult a healthcare professio...

Actions Taken

The decision to withdraw batch 0131G of Flegafortan 1.6 mg/ml, syrup from the national market was revoked after the leaflet was updated and correct repackaging in line with Good Manufacturing Practice...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: It was found that the patient leaflet regarding recommended dosing was inconsistent with the Summary of Product Characteristics, which could lead to incorrect use of the product and overdose manifested by unintended increased volume of bronchial secretions. Potential effects: overdose, increased bronchial secretion, respiratory complications.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: 0131G

Related

Other Recalled Products